Skip to main content
Jafron Biomedical Co.,Ltd. logo

Jafron Biomedical Co.,Ltd. — Investor Relations & Filings

Ticker · 300529 ISIN · CNE100002995 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,842 across all filing types
Latest filing 2022-05-13 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 300529

About Jafron Biomedical Co.,Ltd.

https://www.jafron.com

Jafron Biomedical Co.,Ltd. specializes in the research, development, and manufacturing of biomaterials and equipment for blood purification. The company is a primary provider of hemoperfusion technology, focusing on the production of adsorbent cartridges designed to remove specific toxins and inflammatory mediators from the bloodstream. Its core product portfolio includes the HA series of hemoperfusion cartridges, which are applied in clinical settings for end-stage renal disease, acute poisoning, critical care, and liver failure. Beyond consumables, the company develops blood purification machines and integrated treatment systems. These solutions target clinical applications in nephrology, intensive care, and hepatology. By leveraging advanced resin adsorption technology, the company provides specialized extracorporeal blood treatment options aimed at improving patient outcomes in complex medical conditions.

Recent filings

Filing Released Lang Actions
国浩律师（深圳）事务所关于公司2021年度股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening and proceedings of the 2021 Annual General Meeting (AGM) of the company. It details the legality of the meeting's notice, the qualifications of attendees, the agenda items discussed, and the voting results. The document does not contain the actual annual report or financial statements but rather confirms the procedural compliance and validity of the AGM and its resolutions. This type of document is typically classified as Declaration of Voting Results & Voting Rights Announcements (DVA) because it reports on the official voting outcomes and meeting procedures of the AGM. The document length (8307 characters) and content confirm it is not merely an announcement of a report but a detailed legal opinion on the AGM proceedings and voting results. Therefore, the appropriate classification is DVA with high confidence.
2022-05-13 Chinese
2021年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a "2021年度股东大会决议公告" which translates to "2021 Annual General Meeting Resolution Announcement." It details the resolutions passed at the 2021 Annual General Meeting (AGM) of the company, including voting results on various proposals such as the annual report, board work report, financial statements, profit distribution, and remuneration plans. The document includes meeting attendance, voting methods, and legal opinions on the meeting's validity. It does not contain the full annual report or financial statements themselves but reports on the resolutions and voting outcomes from the AGM. The document length is about 4963 characters, which is consistent with an announcement rather than a full report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially announces the voting results from the AGM.
2022-05-13 Chinese
关于公司高级管理人员股份减持计划实施完毕的公告
Director's Dealing Classification · 100% confidence The document is an announcement regarding the completion of a shareholding reduction plan by a senior management member (the CFO) of the company. It details the number of shares sold, dates, prices, and compliance with relevant laws and regulations. The content focuses on insider share transactions by a company director, specifically the CFO's reduction of shares. There is no financial report, earnings data, or management discussion. The document fits the definition of a Director's Dealing report, which covers personal share transactions by company directors and executives (insider trades). The document length is short and specific to this insider transaction, confirming it is not a full financial report or other category.
2022-05-11 Chinese
关于召开2021年度股东大会的提示性公告
AGM Information Classification · 100% confidence The document is a detailed announcement regarding the convening of the 2021 Annual General Meeting (AGM) of the company, including information about the meeting date, location, voting procedures, agenda items, and instructions for shareholders. It includes references to the 2021 Annual Report and other reports to be discussed at the meeting but does not contain the reports themselves. The document is primarily a notice and instructions for the AGM, not the actual annual report or financial statements. Therefore, it fits the category of AGM Information (AGM-R). The document length is over 5,000 characters and contains detailed AGM-related content, confirming it is not a mere brief announcement or regulatory filing.
2022-05-09 Chinese
关于部分募集资金专户注销完成的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the completion of the cancellation of a specific fundraising special account by the company. It details the background of the fundraising, the management and storage of the funds, and the completion of the account cancellation process. There are no financial statements or detailed financial performance data included. The document is relatively short (2292 characters) and serves as a formal notification about the status of fundraising accounts and related agreements. This fits the profile of a Regulatory Filing (RNS) as it is a regulatory announcement about fundraising account management rather than a full financial report or a capital/financing update announcing new fundraising activities.
2022-04-29 Chinese
关于公司高级管理人员股份减持数量过半的进展公告
Director's Dealing Classification · 100% confidence The document is an announcement regarding the progress of share reduction by a senior management member (the CFO) of the company. It details the number of shares reduced, dates, prices, and compliance with relevant laws and regulations. It is not a financial report, earnings release, or management discussion, but a disclosure of insider share transactions by a company director. This fits the definition of Director's Dealing (DIRS). The document length is short and focused solely on this insider share transaction update, confirming the classification.
2022-04-29 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.